Contribution of dopaminergic and glutamatergic mechanisms to the pathogenesis of motor response complications in Parkinson's disease.
Chase
T N
TN
Experimental Therapeutics Branch, NINDS, National Institutes of Health, Bethesda, Maryland 20892, USA.
Engber
T M
TM
Mouradian
M M
MM
D004298:Dopamine / Q000502:physiology*; D018698:Glutamic Acid / Q000502:physiology*; D006801:Humans; D009069:Movement Disorders / Q000503:physiopathology*; D010300:Parkinson Disease / Q000150:complications* / Q000503:physiopathology*
D018698:Glutamic Acid; D004298:Dopamine